This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Sinopia Biosciences, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Warren S. Wade
Introduction
Warren S. Wade is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. His innovative work has led to the development of unique compounds that hold promise for improving the lives of those affected by this condition.
Latest Patents
Wade holds a patent for isotopically-labelled Trapidil derivatives. This patent focuses on providing isotopically-labelled Trapidil derivatives that are useful for the treatment of Parkinson's disease and movement disorders associated with the disease. The derivatives include deuterated Trapidil derivatives, which are designed to enhance therapeutic efficacy. Additionally, the patent outlines combination therapies that incorporate these isotopically-labelled derivatives along with other therapeutic agents.
Career Highlights
Warren S. Wade is currently associated with Sinopia Biosciences, Inc., where he continues to advance his research and development efforts. His work at the company emphasizes the importance of innovative solutions in the pharmaceutical industry. Wade's dedication to his field is evident through his focused research on treatments for neurological disorders.
Collaborations
Wade collaborates with talented individuals in his field, including Aarash Bordbar and Hiroko Masamune. These partnerships enhance the research and development process, allowing for a more comprehensive approach to tackling complex medical challenges.
Conclusion
Warren S. Wade's contributions to the field of pharmaceuticals, particularly through his patent on isotopically-labelled Trapidil derivatives, highlight his commitment to improving treatments for Parkinson's disease. His work at Sinopia Biosciences, Inc. and collaborations with other professionals further underscore his impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile